WallStreetZenWallStreetZen

NYSEMKT: MAIA
Maia Biotechnology Inc Stock

Overview
ForecastEarningsDividendOwnership
$2.15+0.19 (+9.69%)
Updated Apr 19, 2024
MAIA Price
$2.15
Fair Value Price
N/A
Market Cap
$43.01M
52 Week Low
$0.82
52 Week High
$3.65
P/E
-1.44x
P/B
90.06x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$19.77M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
14.85
Operating Cash Flow
-$13M
Beta
0.29
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MAIA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MAIA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MAIA is poor value based on its book value relative to its share price (90.06x), compared to the US Biotechnology industry average (5.74x)
P/B vs Industry Valuation
MAIA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MAIA due diligence checks available for Premium users.

Be the first to know about important MAIA news, forecast changes, insider trades & much more!

MAIA News

Valuation

MAIA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.44x
Industry
15.81x
Market
40.51x

MAIA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
90.06x
Industry
5.74x
MAIA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MAIA's financial health

Profit margin

Revenue
$0.0
Net Income
-$6.3M
Profit Margin
0%
MAIA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$7.6M
Liabilities
$7.1M
Debt to equity
14.85
MAIA's short-term assets ($7.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MAIA's short-term assets ($7.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MAIA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.0M
Investing
$0.0
Financing
$5.0M
MAIA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MAIA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MAIA$43.01M+9.69%-1.44x90.06x
CALC$43.18M+0.25%-0.52x5.29x
JAGX$43.37M-11.30%-0.09x8.74x
BOLT$42.32M-2.63%-0.61x0.38x
APLM$42.24M-7.45%-0.20x1.02x
View Top Biotech Stocks

Maia Biotechnology Stock FAQ

What is Maia Biotechnology's quote symbol?

(NYSEMKT: MAIA) Maia Biotechnology trades on the NYSEMKT under the ticker symbol MAIA. Maia Biotechnology stock quotes can also be displayed as NYSEMKT: MAIA.

If you're new to stock investing, here's how to buy Maia Biotechnology stock.

What is the 52 week high and low for Maia Biotechnology (NYSEMKT: MAIA)?

(NYSEMKT: MAIA) Maia Biotechnology's 52-week high was $3.65, and its 52-week low was $0.82. It is currently -41.1% from its 52-week high and 162.2% from its 52-week low.

How much is Maia Biotechnology stock worth today?

(NYSEMKT: MAIA) Maia Biotechnology currently has 20,002,826 outstanding shares. With Maia Biotechnology stock trading at $2.15 per share, the total value of Maia Biotechnology stock (market capitalization) is $43.01M.

Maia Biotechnology stock was originally listed at a price of $4.46 in Jul 28, 2022. If you had invested in Maia Biotechnology stock at $4.46, your return over the last 1 years would have been -51.79%, for an annualized return of -51.79% (not including any dividends or dividend reinvestments).

How much is Maia Biotechnology's stock price per share?

(NYSEMKT: MAIA) Maia Biotechnology stock price per share is $2.15 today (as of Apr 19, 2024).

What is Maia Biotechnology's Market Cap?

(NYSEMKT: MAIA) Maia Biotechnology's market cap is $43.01M, as of Apr 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Maia Biotechnology's market cap is calculated by multiplying MAIA's current stock price of $2.15 by MAIA's total outstanding shares of 20,002,826.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.